VEGFB and metabolic dysfunction-associated steatohepatitis: The first model utilised only serum TGs as an explanatory variable, and the second added adipose VEGFB expression to the model, utilising both TGs and adipose VEGFB expression as the explanatory variables for the NAFLD status (steatosis, fibrosis, and NASH).